Home/Filings/4/0001209191-16-088448
4//SEC Filing

Sagent Pharmaceuticals, Inc. 4

Accession 0001209191-16-088448

CIK 0001369786operating

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 3:30 PM ET

Size

4.7 KB

Accession

0001209191-16-088448

Insider Transaction Report

Form 4
Period: 2015-12-31
Drake Lorin
VP, Sales and Marketing
Transactions
  • Tax Payment

    Common Stock

    2015-12-31$15.85/sh853$13,52032,529 total

Issuer

Sagent Pharmaceuticals, Inc.

CIK 0001369786

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001369786

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 3:30 PM ET
Size
4.7 KB